查詢結果分析
相關文獻
- Metformin與子宮內膜癌的檢視
- 荷爾蒙補充治療與子宮內膜癌和乳癌的關係
- 接受手術以及手術後放射線治療的子宮內膜癌預後的分析
- 靈芝水溶液對婦癌細胞生長之抑制效果
- Findings of Persistent Microscopic Hematuria in a Cancer Prevention and Early Detection Program
- Radical Resection and Intraoperative Radiotherapy for a Recurrent Endometrial Cancer after Prolonged Remission Following Aggressive Salvage Therapy: Case Report
- 子宮內膜癌第一期治療之探討
- Endometrial Carcinoma: Evaluation of Depth of Myometrial Invasion by MR Imaging-Preliminary Report
- 子宮內膜癌的一種新分類型態--子宮乳頭狀漿液性上皮細胞癌
- 國人遺傳性非瘜肉群大腸癌的早期分子診斷研究
頁籤選單縮合
題名 | Metformin與子宮內膜癌的檢視=The Effects of Metformin on Endometrial Cancer |
---|---|
作者 | 李耀泰; 陳福民; 沈仁達; 郭宗正; 沈仁達; | 書刊名 | 婦癌醫學期刊 |
卷期 | 43 2016.04[民105.04] |
頁次 | 頁15-19 |
分類號 | 418.271 |
關鍵詞 | 子宮內膜癌; 第II型糖尿病; Endometrial cancer; Metformin; Type 2 diabetes; |
語文 | 中文(Chinese) |
中文摘要 | Metformin是治療第II型糖尿病的主要藥物,最近亦被證明可用在許多癌症的預防與治療。在婦科,罹患第II型糖尿病的子宮內膜癌患者,metformin對治療是有幫助的;但是,對沒有糖尿病的子宮內膜患者是否具有相同功效,則有待更大規模的研究證實之。 |
英文摘要 | Metformin (1, 1-dimethylbiguanide), frequently used in the treatment of type 2 diabetes, has been demonstrated to exert marked chemoprevention and antiproliferative effects against various types of cancer. In gynecologic oncology, metformin has been suggested to exhibit significant treatment efficacy against endometrial cancer in patients with type 2 diabetes. However, the most important question remains unanswered: Will metformin be effective against cancer in patients without diabetes? Further clinical and epidemiological studies are required to examine these issues. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。